BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Biotech Beach

  Ionis Pharma Announces Plans to Open Expanded Access Program to Provide Inotersen to Patients With Hereditary TTR Amyloidosis in the U.S.

  Ionis Pharma announced today that it plans to open an expanded access program for eligible patients with hereditary transthyretin amyloidosis with polyneuropathy in the coming months.

  October 27, 2017

   · 

  6 min read
• Covalon Announces Issuance of Stock Options

  Covalon Technologies Ltd., an advanced medical technologies company, today announced the issuance of 60,000 stock options to financial advisors of the Company.

  October 27, 2017

   · 

  2 min read
• Chi-Med Announces the Full Exercise of Underwriters’ Over-allotment Option

  The underwriters have elected to purchase an additional 1,483,018 ADSs at the Offering price of US$26.50 per ADS.

  October 27, 2017

   · 

  6 min read
• Microbix Completes Second Tranche of Brokered Private Placement

  Microbix has now closed a second tranche of private placement financing for further gross proceeds of $1.17 million, resulting in the issue of 3,882,133 more Units at a price of $0.30 per Unit.

  October 27, 2017

   · 

  4 min read
• Business

  AbbVie Increases Quarterly Dividend by 11 Percent

  The board of directors of AbbVie increased the company’s quarterly cash dividend by 11 percent from $0.64 per share to $0.71 per share.

  October 27, 2017

   · 

  1 min read
• Business

  AbbVie Reports Third-Quarter 2017 Financial Results

  AbbVie announced financial results for the third quarter ended September 30, 2017.

  October 27, 2017

   · 

  41 min read
• Genetown

  Biogen and Ionis Win Prestigious Prix Galien Award for SPINRAZA As Best Biotechnology Product

  The Prix Galien USA Award recognizes extraordinary achievement in scientific innovation that improves the state of human health.

  October 27, 2017

   · 

  8 min read
• Business

  BioAmber Announces Webcast of Fiscal Third Quarter 2017 Financial Results

  BioAmber today announced that it will report financial results for the third quarter 2017 on Tuesday, November 7, 2017 after markets close.

  October 27, 2017

   · 

  2 min read
• Business

  Allergan Board of Directors Announces Fourth Quarter 2017 Cash Dividend and Increases Quarterly Cash Dividend for 2018

  Allergan today announced the record and payment dates for a cash dividend of $0.70 per ordinary share for the fourth quarter of 2017.

  October 27, 2017

   · 

  3 min read
• Pharm Country

  Relmada Therapeutics Announces Notice of Acceptance of Key Patent in Australia Covering NMDA Receptor Antagonist d-Methadone for Treatment of Psychiatric Symptoms

  Relmada Therapeutics announced today that IP Australia has issued a notice of acceptance for patent application number 2013323645 for “D-methadone for the treatment of psychiatric symptoms.""

  October 27, 2017

   · 

  4 min read